Trailing-twelve-month (TTM) revenue is $6.16 Billion with a year-over-year growth of +78.92%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,181,092,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $1,406,802,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17 |
| Q1 FY2026Period ended 2026-03-31 | $1,632,583,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $1,935,464,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $6,155,941,000 |
Current P/S: $389,252,747,100 market capitalization ÷ $6,155,941,000 TTM revenue = 63.23x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.94B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Commercial | $482M | $645M | $834M | $1.0B | $1.3B | $2.1B |
| Government Operating Segment | $610M | $9.0B | $1.1B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| France | $98M | $86M | N/A | N/A | N/A | N/A |
| Geographic Concentration Risk | N/A | N/A |
$6.16B
$6.16 Billion
+78.92%
vs. $3.44B a year ago (TTM)
+35.90%
5 Year compound annual growth rate
1 Year
+78.92%
3 Year
+44.38%
5 Year
+35.90%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.48B | +$1.61B | +56.18% |
| 2024 | $2.87B | +$640.50M | +28.79% |
| 2023 | $2.23B | +$319.14M | +16.75% |
| 2022 | $1.91B | +$363.98M | +23.61% |
| 2021 | $1.54B | +$449.22M | +41.11% |
| 2020 |
TTM Growth
+78.92%
3-Year CAGR
+44.38%
5-Year CAGR
+35.90%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.6B |
| $2.4B |
| N/A |
| N/A |
| $4.5B |
| Rest Of World | $289M | $404M | $524M | $612M | $661M | $728M |
|---|
| UNITED KINGDOM | $132M | $173M | $221M | $235M | $305M | $427M |
|---|
| UNITED STATES | $574M | $879M | $1.2B | $1.4B | $1.9B | $3.3B |
|---|
| $1.09B |
| +$350.12M |
| +47.15% |
| 2019 | $742.55M | +$147.15M | +24.71% |
